Tara Cowling, as the President of Medlior Health Outcomes Research Ltd., has been at the forefront of advancing health outcomes research since founding the company in 2008. With over 20 years of experience in both the public sector and industry, Tara has cultivated a deep...
Tara Cowling, as the President of Medlior Health Outcomes Research Ltd., has been at the forefront of advancing health outcomes research since founding the company in 2008. With over 20 years of experience in both the public sector and industry, Tara has cultivated a deep understanding of the complexities and nuances of health economics and outcomes research (HEOR). Her previous tenure at Alberta Health Services provided her with invaluable insights into the public healthcare landscape, which she has seamlessly integrated into Medlior's strategic approach.
Under Tara’s leadership, Medlior has established a strong reputation for delivering high-quality health outcomes research across North America and Europe. The consultancy specializes in a range of services, including real-world evidence (RWE) generation, health technology assessment (HTA), and the analysis of patient-reported outcomes (PROs). Tara's commitment to employing robust methodologies ensures that clients receive actionable insights that drive decision-making in the pharmaceutical industry, particularly in oncology and other critical therapeutic areas.
Key projects led by Tara and her team have focused on harnessing real-world data (RWD) to inform healthcare policies and improve patient outcomes. By leveraging her extensive network and experience from global public healthcare organizations and academic settings, Tara continues to position Medlior as a leader in the HEOR space. Her vision for the company emphasizes the importance of delivering value through rigorous research that not only meets client needs but also enhances the overall quality of care within the healthcare system. As Medlior looks to the future, Tara remains dedicated to fostering innovation and excellence in health outcomes research, ensuring that the consultancy remains a trusted partner for clients navigating the complexities of healthcare evaluation.
